ArticleBMC gastroenterology2026

Transarterial chemoembolization combined with tyrosine kinase inhibitors and programmed death-1 inhibitors in recurrent intermediate and advanced hepatocellular carcinoma: a single-centre retrospective cohort study.

Wei Fan Sui et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.